You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vismodegib

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

Terminated
Has Results
  • Pontine Glioma
  • Vismodegib
  • Phoenix, Arizona
  • +1 more
Apr 20, 2022

Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma Trial in France (Laboratory

Active, not recruiting
Has Results
  • Clear Cell Chondrosarcoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Bordeaux, France
  • +5 more
Sep 20, 2022

Carcinoma, Basal Cell Trial in Ann Arbor (Vismodegib)

Completed
Has Results
  • Carcinoma, Basal Cell
  • Vismodegib
  • Ann Arbor, Michigan
    University of Michigan Hospital
Sep 29, 2021

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Basal Cell Carcinoma Trial in Germany (Vismodegib)

Completed
  • Basal Cell Carcinoma
  • Vismodegib
  • Gera, Thuringia, Germany
  • +11 more
Feb 10, 2022

Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

Recruiting
  • Basal Cell Carcinoma
  • +10 more
  • Nijmegen, Gelderland, Netherlands
  • +7 more
Jul 14, 2022

Locally Advanced Basal Cell Carcinoma, Skin Cancer, Cutaneous Malignancy Trial in San Francisco, New York (Vismodegib, Radiation

Completed
Has Results
  • Locally Advanced Basal Cell Carcinoma
  • +2 more
  • Vismodegib
  • Radiation therapy
  • San Francisco, California
  • +1 more
Apr 7, 2021

Chronic GVHD Trial in Ann Arbor, Salt Lake City (Laboratory Biomarker Analysis, Vismodegib)

Terminated
Has Results
  • Chronic Graft Versus Host Disease
  • Laboratory Biomarker Analysis
  • Vismodegib
  • Ann Arbor, Michigan
  • +1 more
Jun 22, 2021

Keratocystic Odontogenic Tumor Trial in New York (vismodegib)

Completed
Has Results
  • Keratocystic Odontogenic Tumor
  • vismodegib
  • New York, New York
    NYU Bluestone Center For Cllinical Research
Feb 1, 2021

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Basal Cell Nevus Syndrome, Gorlin's Syndrome Trial in Oakland, New York (Vismodegib, Aminolevulinic acid %20 topical solution)

Completed
Has Results
  • Basal Cell Nevus Syndrome
  • Gorlin's Syndrome
  • Vismodegib
  • Aminolevulinic acid %20 topical solution
  • Oakland, California
  • +2 more
Oct 8, 2020

Vismodegib (Erivedge®) in Advanced Basal Cell Carcinoma (BCC)

Completed
  • Basal Cell Carcinoma
  • Vismodegib
  • Göteborg, Sweden
  • +3 more
Oct 8, 2020

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

Recruiting
  • Glioblastoma, Adult
  • Berlin, Germany
  • +12 more
May 20, 2022

Carcinoma, Basal Cell Trial in Rozzano (Vismodegib, Radiotherapy)

Terminated
  • Carcinoma, Basal Cell
  • Vismodegib
  • Radiotherapy
  • Rozzano, Mi, Italy
    Istituto Clinico humanitas
Jan 27, 2020

Basal Cell Nevus Syndrome Trial (Vismodegib, Nivolumab, Ipilimumab)

Withdrawn
  • Basal Cell Nevus Syndrome
  • Vismodegib
  • +2 more
  • (no location specified)
Dec 16, 2019

Basal Cell Carcinomas Trial in Tucson (Vismodegib, Placebo)

Terminated
Has Results
  • Basal Cell Carcinomas
  • Vismodegib
  • Placebo
  • Tucson, Arizona
    University of Arizona Cancer Center
Jul 30, 2019

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

Recruiting
  • Intracranial Meningioma
  • +2 more
  • Vismodegib
  • +3 more
  • Birmingham, Alabama
  • +707 more
Sep 25, 2022

Vismodegib in Locally Advanced Basal Cell Carcinoma

Completed
  • Carcinoma, Basal Cell
  • Vismodegib
  • Frankfurt, Germany
    Klinik Johann Wolfgang von Goethe Uni; Klinik für Dermatologie,
May 10, 2019

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • vismodegib
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Apr 4, 2019

Skin Basal Cell Carcinoma Trial in Palo Alto (Pembrolizumab, Vismodegib)

Completed
Has Results
  • Skin Basal Cell Carcinoma
  • Pembrolizumab
  • Vismodegib
  • Palo Alto, California
    Stanford University School of Medicine
Mar 6, 2019

Histologically Confirmed Medulloblastoma, Activation of the Sonic Hedgehog (SHH) Pathway Trial in Worldwide (vismodegib,

Terminated
  • Histologically Confirmed Medulloblastoma
  • Activation of the Sonic Hedgehog (SHH) Pathway
  • Marseille, Bouches Du Rhône, France
  • +14 more
May 20, 2019